RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis

William R Colyer JrDivision of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, OH, USAAbstract: The management of renal artery stenosis (RAS) remains controversial. While some evidence suggests that treatment with stent placement is beneficial, randomized trials have failed to...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Colyer Jr, WR
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/afcdb17fadf0460886a3f4200b618615
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:afcdb17fadf0460886a3f4200b618615
record_format	dspace
spelling	oai:doaj.org-article:afcdb17fadf0460886a3f4200b6186152021-12-02T02:49:15ZRX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis1179-1470https://doaj.org/article/afcdb17fadf0460886a3f4200b6186152012-08-01T00:00:00Zhttp://www.dovepress.com/rx-herculink-elitereg-renal-stent-system-a-review-of-its-use-for-the-t-a10578https://doaj.org/toc/1179-1470William R Colyer JrDivision of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, OH, USAAbstract: The management of renal artery stenosis (RAS) remains controversial. While some evidence suggests that treatment with stent placement is beneficial, randomized trials have failed to demonstrate a significant benefit. Ongoing clinical trials should help to better define the role for stenting of RAS while avoiding limitations seen with earlier trials. When it comes to stenting for RAS, several stents have been used; however, many stents which have been used previously and which are still being used are biliary stents that are used &ldquo;off-label.&rdquo; These stents have typically come onto the market through the 510(k) pathway. To date, a total of five stents have been approved by the United States Food and Drug Administration for use in the renal arteries. Of the five stents that have received approval, the Bridge&trade; Extra Support (Medtronic CardioVascular, Santa Rosa, CA) and the Palmaz&reg; (Cordis Corporation, Bridgewater, NJ) stents are no longer available. Currently, the Express&reg; SD (Boston Scientific, Natick, MA), Formula&trade; (Cook Medical, Bloomington, IN), and Herculink Elite&reg; (Abbott Vascular, Santa Clara, CA) stents are Food and Drug Administration approved and available for use. The Herculink Elite is the most recently approved of the renal stents, having received approval in late 2011. The Herculink Elite stent is the only cobalt chromium stent approved for use in the renal arteries. Although trial data are limited and direct comparisons among renal stents is not possible, the Herculink Elite stent has demonstrated good performance. Additionally, the design of the Herculink Elite offers some advantages that may translate into improved outcomes.Keywords: renal artery stenosis, stenting, FDA approvalColyer JrWRDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2012, Iss default, Pp 67-73 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical technology R855-855.5
spellingShingle	Medical technology R855-855.5 Colyer Jr WR RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
description	William R Colyer JrDivision of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, OH, USAAbstract: The management of renal artery stenosis (RAS) remains controversial. While some evidence suggests that treatment with stent placement is beneficial, randomized trials have failed to demonstrate a significant benefit. Ongoing clinical trials should help to better define the role for stenting of RAS while avoiding limitations seen with earlier trials. When it comes to stenting for RAS, several stents have been used; however, many stents which have been used previously and which are still being used are biliary stents that are used &ldquo;off-label.&rdquo; These stents have typically come onto the market through the 510(k) pathway. To date, a total of five stents have been approved by the United States Food and Drug Administration for use in the renal arteries. Of the five stents that have received approval, the Bridge&trade; Extra Support (Medtronic CardioVascular, Santa Rosa, CA) and the Palmaz&reg; (Cordis Corporation, Bridgewater, NJ) stents are no longer available. Currently, the Express&reg; SD (Boston Scientific, Natick, MA), Formula&trade; (Cook Medical, Bloomington, IN), and Herculink Elite&reg; (Abbott Vascular, Santa Clara, CA) stents are Food and Drug Administration approved and available for use. The Herculink Elite is the most recently approved of the renal stents, having received approval in late 2011. The Herculink Elite stent is the only cobalt chromium stent approved for use in the renal arteries. Although trial data are limited and direct comparisons among renal stents is not possible, the Herculink Elite stent has demonstrated good performance. Additionally, the design of the Herculink Elite offers some advantages that may translate into improved outcomes.Keywords: renal artery stenosis, stenting, FDA approval
format	article
author	Colyer Jr WR
author_facet	Colyer Jr WR
author_sort	Colyer Jr
title	RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
title_short	RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
title_full	RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
title_fullStr	RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
title_full_unstemmed	RX Herculink Elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
title_sort	rx herculink elite&reg; renal stent system: a review of its use for the treatment of renal artery stenosis
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/afcdb17fadf0460886a3f4200b618615
work_keys_str_mv	AT colyerjr rxherculinkeliteampregrenalstentsystemareviewofitsuseforthetreatmentofrenalarterystenosis AT wr rxherculinkeliteampregrenalstentsystemareviewofitsuseforthetreatmentofrenalarterystenosis
_version_	1718402119473561600

RX Herculink Elite&amp;reg; renal stent system: a review of its use for the treatment of renal artery stenosis

Ejemplares similares

RX Herculink Elite® renal stent system: a review of its use for the treatment of renal artery stenosis